PAVmed Inc. - Series Z Warrant
PAVmed Inc. - Series Z Warrant
Share · US70387R1225 · PAVMZ (XNAS)
Overview Financial Indicators
No Price
n/a

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
- - 0,00 % -85,45 % -94,67 % -98,64 % -99,92 %

Company Profile for PAVmed Inc. - Series Z Warrant Share

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.

Company Data

Name PAVmed Inc. - Series Z Warrant
Company PAVmed Inc
Symbol PAVMZ
Website https://www.pavmed.com
Primary Exchange XNAS NASDAQ
ISIN US70387R1225
Asset Class Share
Sector Healthcare
Industry Medical - Devices
CEO Dr. Lishan Aklog M.D.
Market Capitalization 11 Mio
Country United States of America
Currency USD
Employees 0,0 T
Address 360 Madison Avenue, 10017 New York
IPO Date 2018-04-10

Ticker Symbols

Name Symbol
NASDAQ PAVMZ

More Shares

Investors who PAVmed Inc. - Series Z Warrant hold also have the following shares in their portfolio:
CDA NATL.RWY 22/32
CDA NATL.RWY 22/32 Bond
JPMORGAN CHASE & CO 4.22% NTS 22/12/22
JPMORGAN CHASE & CO 4.22% NTS 22/12/22 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025